MEI Pharma Inc - Board of Directors Unanimously Agreed on a Strategic Plan to Leverage Recent Positive Voruciclib and Me-344 Clinical Data
MEI Pharma Inc-董事会一致同意一项战略计划,以利用最近积极的Voruciclib和Me-344临床数据
MEI Pharma Inc - Board of Directors Unanimously Agreed on a Strategic Plan to Leverage Recent Positive Voruciclib and Me-344 Clinical Data
MEI Pharma Inc-董事会一致同意一项战略计划,以利用最近积极的Voruciclib和Me-344临床数据
使用浏览器的分享功能,分享给你的好友吧